• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性肿瘤中脯氨酰羟化酶结构域蛋白的基因表达水平降低,而非升高,且与手术切除的非小细胞肺癌患者的不良预后相关。

Gene Expression Levels of the Prolyl Hydroxylase Domain Proteins and but Not Are Decreased in Primary Tumours and Correlate with Poor Prognosis of Patients with Surgically Resected Non-Small-Cell Lung Cancer.

作者信息

Koren Ana, Rijavec Matija, Krumpestar Tomaž, Kern Izidor, Sadikov Aleksander, Čufer Tanja, Korošec Peter

机构信息

University Clinic of Respiratory and Allergic Diseases Golnik, 4204 Golnik, Slovenia.

Faculty of Computer and Information Science, University of Ljubljana, 1000 Ljubljana, Slovenia.

出版信息

Cancers (Basel). 2021 May 12;13(10):2309. doi: 10.3390/cancers13102309.

DOI:10.3390/cancers13102309
PMID:34065840
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8150639/
Abstract

BACKGROUND

Hypoxia correlates with poor prognosis in several cancer types, including lung cancer. Prolyl hydroxylase domain proteins (PHDs) play a role in cell oxygen sensing, negatively regulating the hypoxia-inducible factor (HIF) pathway. Our study aim was to evaluate , and mRNA expression levels in primary tumours and normal lungs of non-small-cell lung cancer (NSCLC) patients and to correlate it with selected regulators of HIF signalling, with clinicopathological characteristics and overall survival (OS).

METHODS

Tumour tissue samples were obtained from 60 patients with surgically resected NSCLC who were treated with radical surgery. In 22 out of 60 cases, matching morphologically normal lung tissue was obtained. , and mRNA expressions were measured using RT-qPCR.

RESULTS

The and mRNA levels in primary tumours were significantly decreased compared to those in normal lungs (both < 0.0001). and expression in tumours was positively correlated ( = 0.82; < 0.0001) and correlated well with HIF pathway downstream genes , and . Decreased and were associated with larger tumour size, higher tumour stage ( only) and squamous cell carcinoma. Patients with low and patients with low expression had shorter OS than patients with high ( = 0.02) and expression ( = 0.01). showed borderline independent prognostic values in multivariate analysis ( = 0.06). In contrast, we found no associations between expression and any of the observed parameters.

CONCLUSIONS

Our results show that reduced expression of and is associated with the development and progression of NSCLC. could be further assessed as a prognostic marker in NSCLC.

摘要

背景

缺氧与包括肺癌在内的多种癌症类型的不良预后相关。脯氨酰羟化酶结构域蛋白(PHD)在细胞氧感应中起作用,对缺氧诱导因子(HIF)通路起负调节作用。我们的研究目的是评估非小细胞肺癌(NSCLC)患者原发性肿瘤和正常肺组织中 、 和 mRNA 的表达水平,并将其与 HIF 信号的选定调节因子、临床病理特征和总生存期(OS)相关联。

方法

从 60 例行根治性手术的 NSCLC 患者中获取肿瘤组织样本。60 例中有 22 例获得了形态学上匹配的正常肺组织。使用 RT-qPCR 测量 、 和 mRNA 的表达。

结果

与正常肺组织相比,原发性肿瘤中的 和 mRNA 水平显著降低(均 < 0.0001)。肿瘤中的 和 表达呈正相关( = 0.82; < 0.0001),并与 HIF 通路下游基因 、 和 密切相关。 和 的降低与肿瘤体积较大、肿瘤分期较高(仅 )和鳞状细胞癌相关。 和 表达低的患者的 OS 比 和 表达高的患者短( = 0.02)和 表达高的患者短( = 0.01)。在多变量分析中, 显示出临界独立预后价值( = 0.06)。相比之下,我们发现 表达与任何观察到的参数之间均无关联。

结论

我们的结果表明, 和 表达降低与 NSCLC 的发生和进展相关。 可作为 NSCLC 的预后标志物进一步评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0484/8150639/8b526ff017b4/cancers-13-02309-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0484/8150639/0ec3b9e4c974/cancers-13-02309-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0484/8150639/b0a8bdad5fd5/cancers-13-02309-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0484/8150639/8b526ff017b4/cancers-13-02309-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0484/8150639/0ec3b9e4c974/cancers-13-02309-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0484/8150639/b0a8bdad5fd5/cancers-13-02309-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0484/8150639/8b526ff017b4/cancers-13-02309-g003.jpg

相似文献

1
Gene Expression Levels of the Prolyl Hydroxylase Domain Proteins and but Not Are Decreased in Primary Tumours and Correlate with Poor Prognosis of Patients with Surgically Resected Non-Small-Cell Lung Cancer.原发性肿瘤中脯氨酰羟化酶结构域蛋白的基因表达水平降低,而非升高,且与手术切除的非小细胞肺癌患者的不良预后相关。
Cancers (Basel). 2021 May 12;13(10):2309. doi: 10.3390/cancers13102309.
2
Expression and DNA methylation levels of prolyl hydroxylases PHD1, PHD2, PHD3 and asparaginyl hydroxylase FIH in colorectal cancer.脯氨酰羟化酶PHD1、PHD2、PHD3及天冬酰胺酰羟化酶FIH在结直肠癌中的表达及DNA甲基化水平
BMC Cancer. 2013 Nov 6;13:526. doi: 10.1186/1471-2407-13-526.
3
The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen.脯氨酰羟化酶与缺氧诱导因子-1α和血管内皮生长因子在人乳腺癌中呈正相关,并对表阿霉素和他莫昔芬的原发性全身治疗有反应而改变。
Breast Cancer Res. 2011 Feb 3;13(1):R16. doi: 10.1186/bcr2825.
4
mRNA overexpression of prolyl hydroxylase PHD3 is inversely related to nuclear grade in renal cell carcinoma.脯氨酰羟化酶PHD3的mRNA过表达与肾细胞癌的核分级呈负相关。
Mol Clin Oncol. 2020 Sep;13(3):11. doi: 10.3892/mco.2020.2076. Epub 2020 Jun 26.
5
DNA methylation analysis of the HIF-1α prolyl hydroxylase domain genes PHD1, PHD2, PHD3 and the factor inhibiting HIF gene FIH in invasive breast carcinomas.浸润性乳腺癌中 HIF-1α 脯氨酰羟化酶结构域基因 PHD1、PHD2、PHD3 和因子抑制 HIF 基因 FIH 的 DNA 甲基化分析。
Histopathology. 2010 Sep;57(3):451-60. doi: 10.1111/j.1365-2559.2010.03633.x. Epub 2010 Aug 19.
6
Overexpression of the HIF hydroxylases PHD1, PHD2, PHD3 and FIH are individually and collectively unfavorable prognosticators for NSCLC survival.HIF 羟化酶 PHD1、PHD2、PHD3 和 FIH 的过表达单独和共同对 NSCLC 患者的生存预后不利。
PLoS One. 2011;6(8):e23847. doi: 10.1371/journal.pone.0023847. Epub 2011 Aug 22.
7
Low nuclear expression of HIF-hydroxylases PHD2/EGLN1 and PHD3/EGLN3 are associated with poor recurrence-free survival in clear cell renal cell carcinoma.低核表达的 HIF-羟化酶 PHD2/EGLN1 和 PHD3/EGLN3 与肾透明细胞癌患者无复发生存率差相关。
Cancer Med. 2024 Feb;13(3):e6998. doi: 10.1002/cam4.6998.
8
Differential and reciprocal regulation between hypoxia-inducible factor-alpha subunits and their prolyl hydroxylases in pulmonary arteries of rat with hypoxia-induced hypertension.缺氧诱导性高血压大鼠肺动脉中缺氧诱导因子-α亚基与其脯氨酰羟化酶之间的差异及相互调节
Acta Biochim Biophys Sin (Shanghai). 2006 Jun;38(6):423-34. doi: 10.1111/j.1745-7270.2006.00174.x.
9
HIF prolyl hydroxylases in the rat; organ distribution and changes in expression following hypoxia and coronary artery ligation.大鼠中的低氧诱导因子脯氨酰羟化酶;器官分布以及缺氧和冠状动脉结扎后表达的变化
J Mol Cell Cardiol. 2006 Jul;41(1):68-77. doi: 10.1016/j.yjmcc.2006.04.009.
10
Expression of key hypoxia sensing prolyl-hydroxylases PHD1, -2 and -3 in pancreaticobiliary cancer.胰腺胆管癌中关键缺氧感应脯氨酰-羟化酶 PHD1、-2 和 -3 的表达。
Histopathology. 2010 Jun;56(7):908-20. doi: 10.1111/j.1365-2559.2010.03566.x. Epub 2010 May 15.

引用本文的文献

1
Prolyl hydroxylase domain enzyme PHD2 inhibits proliferation and metabolism in non-small cell lung cancer cells in HIF-dependent and HIF-independent manners.脯氨酰羟化酶结构域酶PHD2以依赖缺氧诱导因子(HIF)和不依赖HIF的方式抑制非小细胞肺癌细胞的增殖和代谢。
Front Oncol. 2024 Jun 27;14:1370393. doi: 10.3389/fonc.2024.1370393. eCollection 2024.
2
Understanding Hypoxia-Driven Tumorigenesis: The Interplay of HIF1A, DNA Methylation, and Prolyl Hydroxylases in Head and Neck Squamous Cell Carcinoma.理解缺氧驱动的肿瘤发生:HIF1A、DNA 甲基化和脯氨酰羟化酶在头颈部鳞状细胞癌中的相互作用。
Int J Mol Sci. 2024 Jun 12;25(12):6495. doi: 10.3390/ijms25126495.
3

本文引用的文献

1
Novel prognostic molecular markers in lung cancer.肺癌中的新型预后分子标志物
Oncol Lett. 2020 Jul;20(1):9-18. doi: 10.3892/ol.2020.11541. Epub 2020 Apr 15.
2
HIF1A expression correlates with increased tumor immune and stromal signatures and aggressive phenotypes in human cancers.HIF1A 的表达与人类癌症中肿瘤免疫和基质特征的增加以及侵袭性表型相关。
Cell Oncol (Dordr). 2020 Oct;43(5):877-888. doi: 10.1007/s13402-020-00534-4. Epub 2020 Jun 1.
3
Pyruvate Kinase M2 and Cancer: The Role of PKM2 in Promoting Tumorigenesis.丙酮酸激酶M2与癌症:PKM2在促进肿瘤发生中的作用
Osimertinib resistance prognostic gene signature: STRIP2 is associated with immune infiltration and tumor progression in lung adenocarcinoma.
奥希替尼耐药预后基因特征:STRIP2 与肺腺癌的免疫浸润和肿瘤进展相关。
J Cancer Res Clin Oncol. 2023 Nov;149(17):15573-15588. doi: 10.1007/s00432-023-05294-w. Epub 2023 Aug 31.
4
Genome editing and cancer therapy: handling the hypoxia-responsive pathway as a promising strategy.基因组编辑与癌症治疗:以缺氧反应通路为靶点的治疗策略
Cell Mol Life Sci. 2023 Jul 21;80(8):220. doi: 10.1007/s00018-023-04852-2.
5
Evolving Strategies in the Treatment of Anaemia in Chronic Kidney Disease: The HIF-Prolyl Hydroxylase Inhibitors.慢性肾脏病贫血治疗策略的演变:低氧诱导因子脯氨酰羟化酶抑制剂。
Drugs. 2022 Nov;82(16):1565-1589. doi: 10.1007/s40265-022-01783-3. Epub 2022 Nov 9.
6
Development and validation of an epithelial-mesenchymal transition-related gene signature for predicting prognosis.用于预测预后的上皮-间质转化相关基因特征的开发与验证
World J Clin Cases. 2022 Sep 16;10(26):9285-9302. doi: 10.12998/wjcc.v10.i26.9285.
7
Will We Unlock the Benefit of Metformin for Patients with Lung Cancer? Lessons from Current Evidence and New Hypotheses.我们能否为肺癌患者解锁二甲双胍的益处?来自当前证据和新假说的启示。
Pharmaceuticals (Basel). 2022 Jun 24;15(7):786. doi: 10.3390/ph15070786.
8
The multifaceted role of EGLN family prolyl hydroxylases in cancer: going beyond HIF regulation.EGLN 家族脯氨酰羟化酶在癌症中的多效性作用:超越 HIF 调控。
Oncogene. 2022 Jul;41(29):3665-3679. doi: 10.1038/s41388-022-02378-8. Epub 2022 Jun 15.
Front Oncol. 2020 Mar 2;10:159. doi: 10.3389/fonc.2020.00159. eCollection 2020.
4
Prolyl hydroxylase 3 involvement in lung cancer progression under hypoxic conditions: association with hypoxia-inducible factor-1α and pyruvate kinase M2.脯氨酰羟化酶3在低氧条件下参与肺癌进展:与缺氧诱导因子-1α和丙酮酸激酶M2的关联
J Thorac Dis. 2019 Sep;11(9):3941-3950. doi: 10.21037/jtd.2019.08.124.
5
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
6
Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.全球癌症生存趋势监测 2000-14 年(CONCORD-3):对来自 71 个国家 322 个基于人群的登记处的 37513025 名诊断患有 18 种癌症之一的患者的个体记录进行分析。
Lancet. 2018 Mar 17;391(10125):1023-1075. doi: 10.1016/S0140-6736(17)33326-3. Epub 2018 Jan 31.
7
Targeting Hypoxia to Improve Non-Small Cell Lung Cancer Outcome.靶向低氧改善非小细胞肺癌预后。
J Natl Cancer Inst. 2018 Jan 1;110(1). doi: 10.1093/jnci/djx160.
8
Prolyl hydroxylase domain protein 3 and asparaginyl hydroxylase factor inhibiting HIF-1 levels are predictive of tumoral behavior and prognosis in hepatocellular carcinoma.脯氨酰羟化酶结构域蛋白3和抑制缺氧诱导因子-1水平的天冬酰胺酰羟化酶因子可预测肝细胞癌的肿瘤行为和预后。
Oncotarget. 2017 Feb 21;8(8):12983-13002. doi: 10.18632/oncotarget.14677.
9
The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy.缺氧在癌症进展、血管生成、转移及治疗抵抗中的作用。
Hypoxia (Auckl). 2015 Dec 11;3:83-92. doi: 10.2147/HP.S93413. eCollection 2015.
10
Prolyl hydroxylase domain enzymes: important regulators of cancer metabolism.脯氨酰羟化酶结构域酶:癌症代谢的重要调节因子。
Hypoxia (Auckl). 2014 Aug 30;2:127-142. doi: 10.2147/HP.S47968. eCollection 2014.